Friday, May 21, 2021

Psychedelic Symposium: LAMPSS, 5/21-5/23

LAMPSS.org; Faith (Meetup); Jen, Ananda (Dharma Buddhist Meditation), Wisdom Quarterly

Announcing LAMPSS 2021: The Los Angeles Medicinal Psychedelics Society Symposium — now a virtual conference on May 21-23!


This follows the highly praised LAPSS (Los Angeles Psychedelic Science Symposium) at UCLA in 2018. This upcoming online collective discussion will cast light on the dark sides of the psychedelic movement, as well as examine and explore its lighter sides.

It turns out these substances are beneficial.
Decades after the shutdown and demonization of "psychedelic" (entheogenic) medicines initiated by the disastrous Nixon administration in 1970, research into the potential benefits of these medicines finally resumed in 1990, leading to the emergence of a psychedelic renaissance.

Over the ensuing three decades, evidence has mounted that psychedelics such as:
  • psilocybin (magic mushrooms)
  • ayahuasca (Amazonian vine)
  • iboga (African bark)
  • ketamine (Special K)
  • MDMA (Ecstasy)
  • cannabis (CBD/THC)
and others hold promising potential for treating conditions such as depression, anxiety, PTSD, substance abuse disorders, and other treatment-resistant mental health conditions.


Public and media emphasis on the positive aspects of psychedelic medicines, supported by the encouraging results of this research, has been a necessary and crucial approach toward counteracting the stigma and hysteria around these substances — a legacy of inaccurate information and fear tactics promulgated by the "War on Drugs" and made worse by a small number of highly-sensationalized tragedies involving psychedelic misuse.


Now, with the renaissance continuing to gather steam (as evidenced and bolstered by recent ballot measure results), it is... More (videos)
at

No comments:

Post a Comment